Akums Drugs & Pharmaceuticals Ltd share price logo

Akums Drugs Share Price

NSE: AKUMS

BSE: 544222

Small Cap

Healthcare Sector

428.75

+3.95

(+0.93%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Akums Drugs Stock Performance

as on January 27, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹415.00
    ₹433.60
    downward going graph

    3.21%

    Downside

    1.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹405.00
    ₹627.90
    downward going graph

    5.54%

    Downside

    46.45%

    Upside

    downward going graph

Akums Drugs share price movements today

Previous Close
₹424.80
Open
₹433.60
Volume
1.83L
Upper Circuit
₹467.25
Lower Circuit
₹382.35
Day's Low - High
₹415.00 - ₹433.60
52 Week Low - High
₹405.00 - ₹627.90

Akums Drugs Historical Returns

1 Month Return
-4.11 %
3 Month Return
-6.22 %
1 Year Return
-22.71 %
3 Year Return
-46.15 %
5 Year Return
-46.15 %

Akums Drugs Fundamentals

as on January 27, 2026 at 4:01 pm IST

Market Cap

₹6,748.27 Cr

Return on Equity (ROE)

13.15

PE Ratio (TTM)

20.7

Return on capital employed (ROCE)

10.7

Industry PE ratio

39.98

Beta (LTM)

1.27

P/B Ratio

3.15

Dividend Yield

0

PEG Ratio

11.44

Quarterly Earnings Growth YOY

-35.93

EPS (TTM)

22.45

Sector

Pharmaceuticals

Book Value

199.01

Technical Analysis

Akums Drugs Stock Valuation

as on January 27, 2026 at 4:01 pm IST

Akums Drugs in the last 5 years

  • Overview

  • Trends

Lowest (18.75x)

April 7, 2025

Today (20.70x)

January 27, 2026

Industry (39.98x)

January 27, 2026

Highest (66.86x)

August 19, 2024

LowHigh

Today’s Price to Earnings Ratio: 20.70x

Akums Drugs & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akums Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY6,748.27-9.23%0.533434,118
NA3,476.8381.48%0.00183653
NA12.37-7.44%0.00NA51
NA109.93-9.99%0.001265
NA294.2134.43%0.5818137

Analyst Recommendation on Akums Drugs Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Akums Drugs. Average target price of ₹646.67

Source: S&P Global Market Intelligence

Akums Drugs Share Price Target

Get share price movements and forecasts by analysts on Akums Drugs.

What analysts predicted

50.83%UPSIDE

Target Price

₹646.67

Current Price

₹428.75

Analyzed by

3 Analysts

High

₹730

Target

₹646.67

Low

₹600

Akums Drugs target price 646.67, a slight upside of 50.83% compared to current price of ₹428.75. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Akums Drugs Stock’s Investor Sentiment and Interest

Search interest for Akums Drugs & Pharmaceuticals Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Akums Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
969.89
1,181.25
1,082.84
944.21
1,019.11
1,033.09
1,010.41
1,055.55
1,024.03
1,017.53
Other Income
8.34
6.77
9.83
10.46
6.55
17.17
19.34
25.76
26.73
32.37
Total Income
978.23
1,188.03
1,092.67
954.67
1,025.66
1,050.26
1,029.75
1,081.31
1,050.76
1,049.9
Expenses
1,095.16
1,056.83
989.4
941.22
891.1
911.9
889.05
961.63
895.06
923.05
Operating Profit
-125.27
124.42
93.44
2.99
128.01
121.19
121.36
93.92
128.97
94.48
Operating Profit Margin %
-12.92%
10.53%
8.63%
0.32%
12.56%
11.73%
12.01%
8.9%
12.59%
9.29%
Profit Before Interest, Tax and Depreciation
-116.93
131.19
103.26
13.45
134.56
138.35
140.71
119.68
155.7
126.84
Interest
12.15
13.65
12.44
12.38
13.02
11.9
5.13
4.54
23.14
23.3
Depreciation
29.72
30.42
31.55
33.95
34.06
34.87
44.52
40
36.92
37.86
Profit Before Tax
-158.8
87.12
59.27
-32.88
87.48
91.58
91.06
75.14
95.64
65.68
Tax Paid
28.64
54.43
-135.72
6.59
26.28
24.94
24.75
-74.47
30.96
22.98
Profit After Tax
-187.43
32.69
195
-39.47
61.21
66.65
66.31
149.61
64.69
42.7
Total Net profit including share of profit / Loss from associate company
-187.43
32.69
195
-39.47
61.21
66.65
66.31
149.61
64.69
42.7
EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
Actual EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
Adjusted EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
Diluted EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66

Akums Drugs & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
3,671.89
3,654.82
4,178.18
4,118.16
Other Income
22.83
46.11
34.03
68.82
Total Income
3,694.73
3,700.93
4,212.21
4,186.98
Expenses
3,776.59
3,391.57
4,081.23
3,653.68
Operating Profit
-104.7
263.25
96.95
464.48
Operating Profit Margin %
-2.85%
7.2%
2.32%
11.28%
Profit Before Interest, Tax and Depreciation
-81.86
309.35
130.98
533.3
Interest
16.66
46.25
50.61
34.6
Depreciation
94.68
112.81
125.64
153.45
Profit Before Tax
-193.2
150.29
-45.27
345.25
Tax Paid
57.68
52.48
-46.07
1.48
Profit After Tax
-250.87
97.82
0.79
343.78
Total Net profit including share of profit / Loss from associate company
-250.87
97.82
0.79
343.78
EPS
-17.65
6.63
-0.28
22.6
Actual EPS
-17.65
6.63
-0.28
22.6
Adjusted EPS
-8.82
6.63
-0.28
22.6
Diluted EPS
-17.65
6.63
-0.28
22.6

Akums Drugs & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
89.14
28.13
134.89
31.85
176.63
498.26
465.2
Cash Flow from Investing Activities
-122.95
-189.86
-109.38
-234.82
-304.7
-330.8
-547.83
Cash Flow from Financing Activities
37.39
233.02
-95.23
236.04
124.54
-108.03
72.79
Net Cash Flow
3.57
71.28
-69.72
33.07
-3.53
59.44
-9.86

Akums Drugs Stock Shareholding Pattern

Numbers in percentages

Feb 2024
Aug 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
84.91%
75.26%
75.26%
75.26%
75.26%
75.26%
75.26%
75.26%
DII
0%
6.43%
7.52%
7%
7.4%
8.85%
9.28%
14.4%
FII
0%
0%
7.34%
6.36%
5.77%
4.24%
2.28%
1.15%
Public
0%
9.09%
7.15%
8.65%
8.85%
8.93%
10.46%
6.46%
Total Outstanding Shares
14,30,64,350
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
Total Shareholders
8
1,38,205
57,531
68,410
69,366
69,424
75,365
76,869

Mutual Funds that own Akums Drugs Stock

Check out the Mutual Funds with significant holdings in Akums Drugs.

Akums Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Akums Drugs.

  • Akums Drugs & Pharmaceuticals Ltd Earnings Results

    Akums Drugs & Pharmaceuticals Ltd’s net profit fell -37.46% since last year same period to ₹40.78Cr in the Q2 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -35.76% fall in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Akums Drugs Stock

Check stock indices that include Akums Drugs.

BSE Healthcare

₹41,259.05

-0.13 (54.44%)

Nifty Smallcap 250

₹15,345.50

0.20 (30.90%)

Nifty MidSmallcap 400

₹18,970.65

0.42 (78.80%)

BSE Small-Cap

₹46,825.31

-2.19 (1050.74%)

Nifty 500

₹22,819.25

0.50 (113.05%)

Insights on Akums Drugs & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AKUMS stock has moved up by 0.8%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 6.44% to 11.23% in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 75.26% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.28% to 1.15% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 10.46% to 6.46% in Dec 2025 quarter

About Akums Drugs & Pharmaceuticals Ltd



Revenue: ₹1,017.53Cr as on September 2025 (Q2 FY26)
Net Profit: ₹42.70Cr as on September 2025 (Q2 FY26)
Listing date: 06 Aug, 2024
OrganisationAkums Drugs & Pharmaceuticals Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Akums Drugs share price today?

Akums Drugs share price today stands at ₹428.75 as on at the close of the market. Akums Drugs share today touched a day high of ₹433.6 and a low of ₹415.

What is the 52 week high and 52 week low range for Akums Drugs share?

Akums Drugs touched a 52 week high of ₹627.9 and a 52 week low of ₹405. Akums Drugs share price today i.e. is closed at ₹428.75, which is -31.72% down from its 52 week high and 5.86% up from its 52 week low.

What is Akums Drugs's market capitalisation today?

Akums Drugs market capitalisation is ₹6,748.27 Cr as on .

How to buy Akums Drugs shares?

To buy Akums Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AKUMS or Akums Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Akums Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Akums Drugs trading volume today?

Akums Drugs trading volume is 1.83L as on . This means that 1.83L shares of Akums Drugs were bought and sold on the stock market during today's trading session.